Mcdonagh, Luke (2020) Could university patents stand in the way of universal global access to a COVID-19 vaccine? LSE COVID-19 Blog (10 Sep 2020). Blog Entry.
![[img]](http://eprints.lse.ac.uk/style/images/fileicons/text.png) |
Text (covid19_2020-09-10-could-university-patents-stand-in-the-way-of)
- Published Version
Download (90kB) |
Abstract
Would it be right for publicly-funded universities to profit from their role in creating a COVID-19 vaccine? Luke McDonagh (LSE) looks at the case of the Oxford University/AstraZeneca collaboration, noting that its plans to offer non-exclusive, royalty-free licences only apply until the WHO declares the pandemic over.
| Item Type: | Online resource (Blog Entry) |
|---|---|
| Official URL: | https://blogs.lse.ac.uk/covid19/ |
| Additional Information: | © 2020 The Author |
| Divisions: | Law |
| Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine H Social Sciences > HV Social pathology. Social and public welfare. Criminology K Law > K Law (General) |
| Date Deposited: | 12 Oct 2020 13:21 |
| Last Modified: | 14 Sep 2024 02:30 |
| URI: | http://eprints.lse.ac.uk/id/eprint/106811 |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics